ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 503,27
-2,66%
Dow Jones
38 589,16
-0,15%
DAX
18 002,02
-1,43%
Brent Oil
82,275
0,00%
Bitcoin
66 114,89
0,17%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. KALA BIO Inc (KALA)

  7. KALA BIO Inc (KALA) Actualités

KALA KALA BIO Inc

5,91
-0,09 (-1,50%)
15 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
KALA BIO Inc KALA NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,09 -1,50% 5,91 06:00:14
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
6,02 5,90 6,02 5,96 6,00
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
13/6/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/6/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/6/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202422:05EDGAR2Form 8-K - Current report
04/6/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/5/202422:03EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
29/5/202414:00GLOBEKALA BIO to Present at Jefferies Global Healthcare..
14/5/202422:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/5/202422:06EDGAR2Form 8-K - Current report
14/5/202422:05GLOBEKALA BIO Reports First Quarter 2024 Financial Results and..
29/3/202413:00GLOBEKALA BIO Reports Fourth Quarter and Full Year 2023 Financial..
04/3/202413:30EDGAR2Form 8-K - Current report
26/2/202414:00GLOBEKALA BIO to Present at TD Cowen 44th Annual Healthcare..
14/2/202419:09EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/2/202414:00GLOBEKALA BIO to Present at Oppenheimer 34th Annual Healthcare..
19/1/202422:01GLOBEKALA BIO Reports Inducement Grants Under Nasdaq Listing Rule..
05/1/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202314:22EDGAR2Form 8-K - Current report
13/11/202314:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202314:05EDGAR2Form 8-K - Current report
13/11/202314:00GLOBEKALA BIO Reports Third Quarter 2023 Financial Results and..
18/10/202322:04EDGAR2Form SC 13D/A - General statement of acquisition of..
20/9/202322:01GLOBEKALA BIO Reports Inducement Grants Under Nasdaq Listing Rule..
05/9/202314:00GLOBEKALA BIO to Present at H.C. Wainwright 25th Annual Global..
04/8/202314:00GLOBEKALA BIO Reports Second Quarter 2023 Financial Results and..
02/8/202322:01EDGAR2Form 8-K - Current report
02/8/202322:01GLOBEKALA BIO to Participate in Upcoming Investor Conferences in..
02/8/202314:00GLOBEKala Pharmaceuticals Announces Name Change to KALA BIO
19/7/202322:01GLOBEKala Pharmaceuticals Reports Inducement Grants Under Nasdaq..
23/6/202322:01GLOBEKala Pharmaceuticals Reports Inducement Grants Under Nasdaq..

Dernières Valeurs Consultées

NASDAQ
KALA
KALA BIO
LATK
INCOUSDT
Incodium
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés